From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real‐world setting

Melanoma currently lacks a reliable blood‐based biomarker of disease activity, although circulating tumor DNA (ctDNA) may fill this role. We investigated the clinical utility (i.e., impact on clinical outcomes and interpretation of radiographic data) of measuring ctDNA in patients with metastatic or...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowe, Steven P., Luber, Brandon, Makell, Monique, Brothers, Patricia, Santmyer, JoAnn, Schollenberger, Megan D., Quinn, Hannah, Edelstein, Daniel L., Jones, Frederick S., Bleich, Karen B., Sharfman, William H., Lipson, Evan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165998/
https://www.ncbi.nlm.nih.gov/pubmed/30113761
http://dx.doi.org/10.1002/1878-0261.12373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165998/
https://www.ncbi.nlm.nih.gov/pubmed/30113761
http://dx.doi.org/10.1002/1878-0261.12373

Ejemplares similares